Re/Max Holdings (RMAX) Share Value Declined While Confluence Investment Management Decreased by $9.69 Million Its Stake; Palo Alto Investors Has Trimmed Its Abiomed (ABMD) Holding by $2.69 Million; Market Valuation Rose

February 24, 2018 - By David King

Confluence Investment Management Llc decreased its stake in Re/Max Holdings Inc. (RMAX) by 73.43% based on its latest 2017Q3 regulatory filing with the SEC. Confluence Investment Management Llc sold 153,757 shares as the company’s stock declined 9.87% while stock markets rallied. The institutional investor held 55,623 shares of the finance company at the end of 2017Q3, valued at $3.54M, down from 209,380 at the end of the previous reported quarter. Confluence Investment Management Llc who had been investing in Re/Max Holdings Inc. for a number of months, seems to be less bullish one the $1.66 billion market cap company. The stock increased 8.72% or $4.4 during the last trading session, reaching $54.85. About 257,863 shares traded or 75.41% up from the average. RE/MAX Holdings, Inc. (NYSE:RMAX) has risen 40.84% since February 24, 2017 and is uptrending. It has outperformed by 24.14% the S&P500.

William Leland Edwards decreased its stake in Abiomed Inc (ABMD) by 0.82% based on its latest 2017Q3 regulatory filing with the SEC. Palo Alto Investors Llc sold 15,984 shares as the company’s stock rose 15.32% with the market. The hedge fund run by William Leland Edwards held 1.94M shares of the health care company at the end of 2017Q3, valued at $326.29 million, down from 1.95 million at the end of the previous reported quarter. Palo Alto Investors Llc who had been investing in Abiomed Inc for a number of months, seems to be less bullish one the $11.89B market cap company. The stock increased 1.70% or $4.48 during the last trading session, reaching $268.45. About 367,297 shares traded. ABIOMED, Inc. (NASDAQ:ABMD) has risen 40.97% since February 24, 2017 and is uptrending. It has outperformed by 24.27% the S&P500.

Among 13 analysts covering RE/MAX Holdings (NYSE:RMAX), 3 have Buy rating, 3 Sell and 7 Hold. Therefore 23% are positive. RE/MAX Holdings had 17 analyst reports since August 11, 2015 according to SRatingsIntel. The stock of RE/MAX Holdings, Inc. (NYSE:RMAX) earned “Underperform” rating by Bank of America on Friday, June 30. The rating was upgraded by JMP Securities to “Mkt Perform” on Wednesday, November 18. Wood initiated RE/MAX Holdings, Inc. (NYSE:RMAX) rating on Thursday, March 31. Wood has “Market Perform” rating and $34 target. The stock of RE/MAX Holdings, Inc. (NYSE:RMAX) has “Buy” rating given on Thursday, September 28 by Piper Jaffray. Morgan Stanley downgraded the stock to “Equal Weight” rating in Wednesday, August 19 report. The stock has “Underweight” rating by JP Morgan on Friday, December 15. Keefe Bruyette & Woods maintained RE/MAX Holdings, Inc. (NYSE:RMAX) rating on Friday, October 6. Keefe Bruyette & Woods has “Hold” rating and $56.0 target. The stock has “Sell” rating by J.P. Morgan on Friday, December 15. The rating was downgraded by Stephens to “Equal-Weight” on Monday, August 7. Compass Point upgraded the stock to “Neutral” rating in Friday, December 22 report.

Investors sentiment is 1.19 in Q3 2017. Its the same as in 2017Q2. It is flat, as 8 investors sold RMAX shares while 45 reduced holdings. only 13 funds opened positions while 50 raised stakes. 17.93 million shares or 0.28% more from 17.88 million shares in 2017Q2 were reported. Germany-based Deutsche Retail Bank Ag has invested 0% in RE/MAX Holdings, Inc. (NYSE:RMAX). Aperio Gp Ltd Liability Company invested 0% of its portfolio in RE/MAX Holdings, Inc. (NYSE:RMAX). Tci Wealth Advisors holds 0% or 27 shares. Putnam Invests Limited invested in 0.01% or 81,549 shares. Riverhead Cap Mgmt Ltd Limited Liability Company owns 1,003 shares or 0% of their US portfolio. Texas Permanent School Fund has 0.01% invested in RE/MAX Holdings, Inc. (NYSE:RMAX) for 12,920 shares. Geode Mgmt Limited Liability Corporation reported 139,913 shares. Jpmorgan Chase And holds 0.01% of its portfolio in RE/MAX Holdings, Inc. (NYSE:RMAX) for 420,436 shares. Aqr Cap Mngmt Limited Co holds 0% or 21,553 shares. Ameritas Prns has invested 0% in RE/MAX Holdings, Inc. (NYSE:RMAX). California Public Employees Retirement Systems holds 0% or 8,230 shares. Metropolitan Life Ny holds 0.01% or 12,589 shares. Federated Pa reported 0% stake. Advisory Ser Networks Ltd Liability Com holds 0% of its portfolio in RE/MAX Holdings, Inc. (NYSE:RMAX) for 101 shares. Schroder Management Grp accumulated 0% or 7,684 shares.

Confluence Investment Management Llc, which manages about $2.30B and $5.22B US Long portfolio, upped its stake in Microsoft Corp. (NASDAQ:MSFT) by 5,600 shares to 1.48M shares, valued at $109.97 million in 2017Q3, according to the filing. It also increased its holding in Colgate (NYSE:CL) by 23,110 shares in the quarter, for a total of 1.33M shares, and has risen its stake in Kinder Morgan Inc. (NYSE:KMI).

Among 14 analysts covering Abiomed (NASDAQ:ABMD), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. Abiomed had 33 analyst reports since August 4, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Friday, September 29 by SunTrust. The company was maintained on Friday, February 16 by SunTrust. The stock of ABIOMED, Inc. (NASDAQ:ABMD) earned “Outperform” rating by Leerink Swann on Wednesday, May 4. The stock of ABIOMED, Inc. (NASDAQ:ABMD) earned “Equal-Weight” rating by Morgan Stanley on Friday, February 2. The stock of ABIOMED, Inc. (NASDAQ:ABMD) earned “Buy” rating by Guggenheim on Wednesday, December 7. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Buy” rating given on Thursday, February 1 by Jefferies. The stock of ABIOMED, Inc. (NASDAQ:ABMD) earned “Buy” rating by Leerink Swann on Thursday, October 12. The stock has “Buy” rating by Piper Jaffray on Thursday, January 4. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Hold” rating given on Wednesday, August 5 by Piper Jaffray. Jefferies maintained the stock with “Buy” rating in Thursday, December 21 report.

Analysts await ABIOMED, Inc. (NASDAQ:ABMD) to report earnings on May, 3. They expect $0.63 earnings per share, up 90.91% or $0.30 from last year’s $0.33 per share. ABMD’s profit will be $27.89M for 106.53 P/E if the $0.63 EPS becomes a reality. After $0.70 actual earnings per share reported by ABIOMED, Inc. for the previous quarter, Wall Street now forecasts -10.00% negative EPS growth.

Palo Alto Investors Llc, which manages about $1.30B and $2.37B US Long portfolio, upped its stake in Epizyme Inc (NASDAQ:EPZM) by 700,000 shares to 6.40M shares, valued at $121.89M in 2017Q3, according to the filing. It also increased its holding in Biomarin Pharmaceutical Inc (NASDAQ:BMRN) by 53,800 shares in the quarter, for a total of 2.44 million shares, and has risen its stake in Acadia Pharmaceuticals Inc (NASDAQ:ACAD).

Investors sentiment decreased to 1.3 in 2017 Q3. Its down 0.13, from 1.43 in 2017Q2. It dropped, as 27 investors sold ABMD shares while 89 reduced holdings. 55 funds opened positions while 96 raised stakes. 38.51 million shares or 1.21% less from 38.99 million shares in 2017Q2 were reported. Walleye Trading Ltd Liability has 1,189 shares for 0% of their portfolio. Bancorporation Of America De holds 0% or 24,082 shares in its portfolio. Tirschwell Loewy holds 2.07% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD) for 81,155 shares. Arizona State Retirement System has invested 0.05% in ABIOMED, Inc. (NASDAQ:ABMD). Signaturefd Llc has invested 0.11% in ABIOMED, Inc. (NASDAQ:ABMD). Ing Groep Nv reported 0% in ABIOMED, Inc. (NASDAQ:ABMD). 27,700 were reported by Dupont Cap. Eagle Asset Management Inc holds 0.23% or 239,064 shares. Washington-based Tradewinds Capital Ltd Liability Com has invested 0.01% in ABIOMED, Inc. (NASDAQ:ABMD). Grp One Trading Ltd Partnership owns 102 shares for 0% of their portfolio. State Of Tennessee Treasury Department holds 0.03% in ABIOMED, Inc. (NASDAQ:ABMD) or 30,000 shares. Hamilton Lane Advsr Limited Liability Co invested in 15,414 shares. Investment House Ltd Com has 0.09% invested in ABIOMED, Inc. (NASDAQ:ABMD). 55,943 are owned by D E Shaw And. Blair William And Com Il holds 0.5% or 398,922 shares.

Since August 24, 2017, it had 0 insider buys, and 3 selling transactions for $7.46 million activity. ROSE ERIC A MD sold $142,554 worth of ABIOMED, Inc. (NASDAQ:ABMD) on Wednesday, August 30.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: